The current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous atrophy). These tests are certainly invasive and unpleasant, but more than that, they are useless in cases where a patient is already following a gluten-free diet. These patients must then undergo a “gluten challenge” of up to eight weeks, during which time they reintroduce gluten-containing foods into their diet, and suffer the consequences. Only then will the blood test and biopsy accurately reveal the hallmarks necessary for an accurate diagnosis.
1/11/2018
New Testing Option for Possible Celiac Disease Sufferers
Recent Posts
- Celiac Disease Foundation and SSCD Submit Comments on FDA Draft Guidance for Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet
- Celiac Disease Foundation Excellence in Celiac Disease Research and Young Investigator Prize Recipients Donate Prize Funds to Benefit the Celiac Community
- CDF Announces Recipients of Inaugural Celiac Disease Research Prizes
- New Tool in Development to Improve Pediatric Celiac Disease Research - Marilyn's Message April 2022
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Research News
- Trending Topics
Marilyn's Message
5/11/2022
Read moreCDF Announces Recipients of Inaugural Celiac Disease Research Prizes